Thomas A. Collet

Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO.

Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI.

Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA.

Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida.

Neural Intervention Technologies, Inc. manufactures medical services. The company was founded by Daryl Kipke and Thomas A. Collet on September 12, 2005 and is headquartered in Ann Harbor, MI.

Meditrina Pharmaceuticals, Inc. operated as a clinical-stage pharmaceutical company that develops and commercializes medical therapies that threat women's reproductive system disorders, with a focus on gynecological and aromatase-mediated conditions with serious unmet medical needs such as endometriosis and uterine fibroids. The company was founded by Thomas A. Collet and Holly Vene in 2006 and was headquartered in Ann Arbor, MI.

Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet.